Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

70 results

Sort By:

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Study ID: NCT06067828
Start Date: 2023-10-24
End Date: 2025-08-25
Study Type

Interventional

Study Phase

Phase3

No. of Participants

180

Intervention / Treatment

Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate

Treatment B: Budesonide and Formoterol Fumarate

Treatment C : Placebo

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Pulmonary Rehabilitation for Rural Patients With COPD

Study ID: NCT06847061
Start Date: 2025-04-01
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

306

Intervention / Treatment

Pulmonary rehabilitation program

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects

Study ID: NCT05239793
Start Date: 2022-11-22
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

Njoy e-cigarette

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Lung Microbiome and Inflammation in Early COPD

Study ID: NCT02777879
Start Date: 2014-05
End Date: 2030-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

230

Intervention / Treatment

Bronchoscopy

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study

Study ID: NCT01177618
Start Date: 1994-07
End Date: 2027-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment
Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease

Study ID: NCT05955482
Start Date: 2023-07-24
End Date: 2025-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

NuvoAir Clinical Service

Sponsor

NuvoAir Medical PC

Source: clinicaltrials.gov

Share:
Add to list

Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction

Study ID: NCT05257681
Start Date: 2022-05-24
End Date: 2026-05-24
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Interlobar fissure completion and pleural adhesiolysis

Sponsor

Beth Israel Deaconess Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Semaglutide in Advanced Lung Disease

Study ID: NCT05746039
Start Date: 2024-01-29
End Date: 2025-12-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

8

Intervention / Treatment

Semaglutide Pen Injector

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Study ID: NCT05612035
Start Date: 2023-03-16
End Date: 2029-10-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Frespaciguat

Placebo

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

STRIVE Post-Market Registry Study

Study ID: NCT04302272
Start Date: 2021-10-09
End Date: 2028-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Spiration Valve System (SVS)

Sponsor

Olympus Corporation of the Americas

Source: clinicaltrials.gov

Share:
Add to list